UPDATED Sep 30, 2025
Explore the Global Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
KOAN | US$0.012 | -9.9% | 66.2% | US$3.0m | n/a | PE2.4x | n/a | n/a | ||
HCWB | US$3.70 | -3.6% | -81.1% | US$8.3m | US$35.00 | PS9.6x | E-19.7% | n/a | ||
SMSLIFE | ₹1,127.70 | -0.009% | -22.2% | ₹3.4b | n/a | PE19.7x | n/a | 0.1% | ||
PKTX | US$0.0055 | -12.7% | -43.2% | US$2.5m | n/a | PB6.6x | n/a | n/a | ||
ACRV | US$1.81 | -0.5% | -74.1% | US$57.2m | US$11.17 | PB0.4x | E-8.7% | n/a | ||
BARI | ₪60.81 | -1.0% | 21.1% | ₪32.3m | n/a | n/a | n/a | n/a | ||
20B | €0.18 | -1.7% | 25.4% | €19.0m | n/a | PS197.3x | n/a | n/a | ||
ATHA | US$4.14 | -1.9% | -8.0% | US$16.6m | US$4.00 | PB0.5x | E28.6% | n/a | ||
ATON | US$5.39 | -2.5% | -12.4% | US$12.6m | n/a | PE-1.8x | n/a | n/a | ||
BOD | AU$0.024 | -7.7% | -65.2% | AU$4.3m | n/a | PS1.3x | n/a | n/a | ||
THAR | US$2.84 | -2.1% | 18.3% | US$16.0m | n/a | PB42.6x | n/a | n/a | ||
SBX | €2.93 | -1.7% | -52.0% | €19.9m | €11.80 | n/a | E85.0% | n/a | ||
PASG | US$8.03 | -1.4% | -38.1% | US$25.9m | US$59.25 | PB0.7x | E46.1% | n/a | ||
RFL | US$1.36 | -0.7% | -30.6% | US$48.1m | n/a | PS65.2x | n/a | n/a | ||
KNB | UK£0.0022 | -25.0% | -82.0% | UK£1.4m | n/a | PS1.2x | n/a | n/a | ||
AKTX | US$1.01 | -1.1% | -66.3% | US$33.3m | US$4.53 | PB1.3x | E-27.5% | n/a | ||
ADTX | US$0.75 | -8.8% | -99.9% | US$4.1m | n/a | PS310.6x | n/a | n/a | ||
MBIO | US$1.52 | -3.2% | -86.6% | US$11.4m | n/a | PB3.8x | n/a | n/a | ||
IXC | AU$0.15 | -3.1% | 106.7% | AU$11.6m | n/a | PS50.8x | n/a | n/a | ||
ACHF.F | US$0.92 | -0.6% | -30.5% | US$61.5m | n/a | PE-35.6x | n/a | n/a | ||
FA0 | €0.011 | -4.2% | -56.1% | €8.9m | n/a | PS9.1x | n/a | n/a | ||
CIZ | UK£0.015 | -6.3% | -26.8% | UK£5.9m | n/a | PB72.5x | n/a | n/a | ||
SYBX | US$1.67 | -1.9% | 13.5% | US$19.9m | n/a | PB1.5x | n/a | n/a | ||
PCSA | US$0.19 | -3.9% | -85.6% | US$10.0m | US$1.00 | PB1.6x | E66.1% | n/a |